PR push looms after Campto owner shift

A PR contract for colorectal cancer brand Campto could be up for grabs within weeks as Pfizer prepares to take control of it from Aventis.

Pfizer has agreed to buy Campto for around £330m as French drugs giant Sanofi-Synthelabo bids to comply with regulatory concerns as it progresses with its acquisition of Aventis, the Franco-German firm that currently markets Campto.

A spokeswoman for Pfizer, whose acquisition of Campto is conditional on the successful completion of the Sanofi-Aventis deal, said: ‘As we normally include PR in our promotional activities, and normally include a PR or comms agency on our product teams, it is likely we may do the same with Campto.’

Aventis has formerly used various PR agencies to promote Campto although PR backing for the brand has been minimal in the past few months, with the promotional emphasis placed on medical education and sales reps.

PR for Campto was most recently handled by Interaction Marketing and Public Relations Consultants, which promoted it until February.

Other products in the bowel cancer market include Sanofi’s own Eloxatin, well-established generic treatment 5FU and Roche Pharmaceuticals’ Xeloda.

Additional PR contracts that could be up for grabs as a result of the Sanofi-Aventis deal are blood-thinning brands Fraxiparine and Arixtra, which Sanofi has agreed to transfer to GlaxoSmithKline (PRWeek, 7 May).

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Sky adds Fever PR to its roster after splitting with Cake

Sky adds Fever PR to its roster after splitting with Cake

Pay-TV giant Sky has added Fever PR to its agency line-up for a wide-ranging brief covering products and services.

Max Clifford trial jury to continue deliberations after Easter break

Max Clifford trial jury to continue deliberations after Easter break

The jury in the trial of celebrity publicist Max Clifford has been sent home for Easter and will reconvene on Tuesday for further deliberations about its verdicts on 11 charges of indecent assault.

Home Office brings in Munro & Forster to campaign against FGM

Home Office brings in Munro & Forster to campaign against FGM

The Home Office has tasked Munro & Forster (M&F) with supporting its campaign to eradicate female genital mutilation (FGM) as part of a wider retained brief.

Former White House press secretary Dee Dee Myers to join Warner Bros

Former White House press secretary Dee Dee Myers to join Warner Bros

Warner Bros has appointed former White House press secretary Dee Dee Myers as EVP for worldwide corporate communications and public affairs, effective September 2.